{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:32:49Z","timestamp":1790674369398,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T00:00:00Z","timestamp":1536796800000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R56AI114793-01"],"award-info":[{"award-number":["1R56AI114793-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science Foundation Graduate Research Fellowship"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.vaccine.2017.08.013","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T02:32:06Z","timestamp":1504233126000},"page":"5373-5380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["A single dose and long lasting vaccine against pandemic influenza through the controlled release of a heterospecies tandem M2 sequence embedded within detoxified bacterial outer membrane vesicles"],"prefix":"10.1016","volume":"35","author":[{"given":"Hannah C.","family":"Watkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina L.","family":"Pagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah R.","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Posada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"DeLisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Putnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.08.013_b0005","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jconrel.2015.07.029","article-title":"Single-injection vaccines: Progress, challenges, and opportunities","volume":"219","author":"McHugh","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.08.013_b0010","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.08.013_b0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2007.09.013","article-title":"Nano\/micro technologies for delivering macromolecular therapeutics using poly (D, L-lactide-co-glycolide) and its derivatives","volume":"125","author":"Mundargi","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.08.013_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00185","article-title":"Bioerodable PLGA-based microparticles for producing sustained-release drug formulations and strategies for improving drug loading","volume":"7","author":"Han","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.vaccine.2017.08.013_b0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/erm.09.15","article-title":"Current advances in research and clinical applications of PLGA-based nanotechnology","volume":"9","author":"L\u00fc","year":"2009","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.vaccine.2017.08.013_b0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2014.03.053","article-title":"An overview of clinical and commercial impact of drug delivery systems","volume":"190","author":"Anselmo","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.08.013_b0035","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","article-title":"PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity","volume":"12","author":"Silva","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.08.013_b0040","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.vaccine.2014.12.059","article-title":"Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation","volume":"33","author":"Silva","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.013_b0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2006.10.036","article-title":"Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres","volume":"334","author":"Mao","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2017.08.013_b0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0168-3659(99)00275-8","article-title":"Formulation of poly(d, l-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery","volume":"66","author":"Tinsley-Bown","year":"2000","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.08.013_b0055","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.vaccine.2016.01.028","article-title":"Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB\/c mice","volume":"34","author":"Rappazzo","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.013_b0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.copbio.2014.02.018","article-title":"Microbial biosynthesis of designer outer membrane vesicles","volume":"29","author":"Baker","year":"2014","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.vaccine.2017.08.013_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2017.05.003","article-title":"Designer outer membrane vesicles as immunomodulatory systems\u2013Reprogramming bacteria for vaccine delivery","author":"Gnopo","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2017.08.013_b0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jmb.2008.03.076","article-title":"Engineered bacterial outer membrane vesicles with enhanced functionality","volume":"380","author":"Kim","year":"2008","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2017.08.013_b0075","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.0805532107","article-title":"Delivery of foreign antigens by engineered outer membrane vesicle vaccines","volume":"107","author":"Chen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2017.08.013_b0080","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1016\/j.vaccine.2014.04.062","article-title":"Protective efficacy of a bacterially produced modular capsomere presenting M2e from influenza: extending the potential of broadly cross-protecting epitopes","volume":"32","author":"Wibowo","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.013_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2017.01.010","article-title":"Safe recombinant outer membrane vesicles that display M2e elicit heterologous influenza protection","author":"Watkins","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2017.08.013_b0090","doi-asserted-by":"crossref","first-page":"e112802","DOI":"10.1371\/journal.pone.0112802","article-title":"Mechanistic insight into the Th1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles","volume":"9","author":"Rosenthal","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.08.013_b0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.addr.2015.04.008","article-title":"Drug encapsulated polymeric microspheres for intracranial tumor therapy: a review of the literature","volume":"91","author":"Floyd","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2017.08.013_b0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2017.08.013_b0105","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0264-410X(98)00323-5","article-title":"Biodegradable microspheres containing influenza A vaccine: immune response in mice","volume":"17","author":"Hilbert","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.013_b0110","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/02652040903059239","article-title":"Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres","volume":"27","author":"Zhao","year":"2010","journal-title":"J Microencapsul"},{"key":"10.1016\/j.vaccine.2017.08.013_b0115","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jconrel.2009.10.033","article-title":"Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery","volume":"142","author":"Rajapaksa","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.08.013_b0120","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1073\/pnas.0804897106","article-title":"Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome","volume":"106","author":"Sharp","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2017.08.013_b0125","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1586\/erv.10.89","article-title":"Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses","volume":"9","author":"Oyewumi","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.08.013_b0130","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1016\/j.vaccine.2016.08.009","article-title":"Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly (D, L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens","volume":"34","author":"Singh","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.013_b0135","doi-asserted-by":"crossref","first-page":"e0151922","DOI":"10.1371\/journal.pone.0151922","article-title":"Entrapment of H1N1 influenza virus derived conserved peptides in PLGA nanoparticles enhances T cell response and vaccine efficacy in pigs","volume":"11","author":"Hiremath","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.08.013_b0140","doi-asserted-by":"crossref","first-page":"e13162","DOI":"10.1371\/journal.pone.0013162","article-title":"Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses","volume":"5","author":"Price","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.08.013_b0145","doi-asserted-by":"crossref","first-page":"7245","DOI":"10.1016\/j.vaccine.2015.10.123","article-title":"Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine","volume":"33","author":"Carignan","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.013_b0150","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.08.013_b0155","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.addr.2012.09.004","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"64","author":"Anderson","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2017.08.013_b0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/adhm.201300139","article-title":"Implantable silk composite microneedles for programmable vaccine release kinetics and enhanced immunogenicity in transcutaneous immunization","volume":"3","author":"DeMuth","year":"2014","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.vaccine.2017.08.013_b0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2016.05.012","article-title":"Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release","volume":"233","author":"Tzeng","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.08.013_b0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2006.01.012","article-title":"Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres","volume":"112","author":"Feng","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.08.013_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines3010105","article-title":"M2e-based universal influenza A vaccines","volume":"3","author":"Deng","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2017.08.013_b0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/geronj\/30.3.257","article-title":"Life-Span and the inheritance of longevity of inbred mice","volume":"30","author":"Goodrick","year":"1975","journal-title":"J Gerontol"},{"key":"10.1016\/j.vaccine.2017.08.013_b0185","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/infdis\/jiu648","article-title":"Raising expectations for subunit vaccine","volume":"211","author":"Schiller","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.013_b0190","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1016\/j.biomaterials.2007.08.015","article-title":"Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response","volume":"28","author":"Kanchan","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2017.08.013_b0195","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2005.09.015","article-title":"Biodegradable microspheres alone do not stimulate murine macrophages in vitro, but prolong antigen presentation by macrophages in vitro and stimulate a solid immune response in mice","volume":"109","author":"Luzardo-Alvarez","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.08.013_b0200","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1016\/j.vaccine.2014.05.071","article-title":"Eliciting cytotoxic T-lymphocyte responses from synthetic vectors containing one or two epitopes in a C57BL\/6 mouse model using peptide-containing biodegradable microspheres and adjuvants","volume":"32","author":"Rubsamen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.013_b0205","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2014.07.040","article-title":"Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: A comparative study","volume":"192","author":"Cruz","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.08.013_b0210","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2015.08.019","article-title":"Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease","volume":"216","author":"Herrmann","year":"2015","journal-title":"J Control Release"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17310800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17310800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:22:55Z","timestamp":1759400575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17310800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":42,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0264410X17310800"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.08.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single dose and long lasting vaccine against pandemic influenza through the controlled release of a heterospecies tandem M2 sequence embedded within detoxified bacterial outer membrane vesicles","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}